EverZom x INITS – A Trusted Partnership

We’re proud to collaborate with EverZom, a biotech company pioneering extracellular vesicle-based therapies. EverZom has successfully developed an innovation platform protected by several patents, covering the entire technological value chain: cell sourcing, exosome generation, exosome loading, and formulation.

EVerZom is currently developing a drug candidate targeting the healing of digestive tissues, with Crohn’s fistula as the primary indication.

 Here’s what Jeanne VOLATRON, CEO of EverZom had to say about collaborating with INITS:

“INITS supported us in our first request for a scientific opinion from the EMA to validate our CMC strategy. We were extremely satisfied with the collaborative approach to regulatory dossier preparation, submission and interaction with the regulatory authorities. Many thanks to INITS for their professionalism and responsiveness.
We're already planning what's next with the brilliant Inits team!”

We’re thrilled to continue supporting EverZom as they advance their innovative platform toward clinical development!

#INITS #EverZom #Biotech #RegulatoryAffairs #CMC #EMA #Innovation #Partnership #Exosomes